Bleakley Financial Group’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,256
Closed -$7.14K 951
2024
Q4
$7.14K Sell
10,256
-112
-1% -$104 ﹤0.01% 1047
2024
Q3
$9.95K Sell
10,368
-582
-5% -$588 ﹤0.01% 1022
2024
Q2
$10.1K Buy
+10,950
New +$7.99K ﹤0.01% 1012
2023
Q4
Sell
-16,942
Closed -$11.2K 974
2023
Q3
$11.2K Buy
+16,942
New +$11.7K ﹤0.01% 876

Other funds holding TLSA

Bleakley Financial Group's TLSA Position: Q1 2025 in Review

Bleakley Financial Group sold out of Tiziana Life Sciences (TLSA) in Q1 2025, closing a stake of 10,256 shares — an estimated $7.14K sold.

Bleakley Financial Group first reported a position in TLSA in Q3 2023 and held it in 4 quarters. The position peaked at $11.2K in Q3 2023. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2025.

  • Bleakley Financial Group reported no remaining Tiziana Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 10,256 Tiziana Life Sciences shares in Q1 2025, an estimated $7.14K.
  • Bleakley Financial Group first reported a position in Tiziana Life Sciences in Q3 2023 and held it in 4 quarters.
  • Bleakley Financial Group's Tiziana Life Sciences position peaked at $11.2K in Q3 2023.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.